Dupilumab Boosts Asthma Control and Lung Function

In a phase 4 trial, dupilumab effectively reduces airway inflammation and mucus plugging, improving lung function and asthma control in patients with moderate to severe type 2 asthma.
Medscape Medical News

source https://www.medscape.com/viewarticle/dupilumab-boosts-lung-function-patients-type-2-asthma-2025a10006fb?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?